Clinical Pharmacology Considerations for Peptide Drug Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 14, 2023
December 13, 2023
1609c8ed-4d50-4235-8a00-9c63176affe8
Related Documents
Psychedelic Drugs: Considerations for Clinical Investigations
Guidance DocumentJune 23, 2023Center for Drug Evaluation and Research
Quality Considerations for Topical Ophthalmic Drug Products
Guidance DocumentDecember 27, 2023Center for Drug Evaluation and Research
General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products
Guidance DocumentSeptember 7, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.